COMPANY

Alleviant Medical, Inc.

HQ: Austin, TX source · alleviantmedical.com ↗ · Southwest

Location: Austin, TX · source · Oct 14, 2026

Profile checked Oct 10, 2026

Keywords: Heart Failure congestive heart failure ALV1 System Alleviant ALV1 System ALV1System

Funding and NIH signals

NIH award NIH awarded $996K (SBIR Phase II 5R44HL142440-06, continuation, notice May 13, 2026). NIH RePORTER 5R44HL142440-06 (May 13, 2026)
Evidence (1 event)
- May 13, 2026 · NIH RePORTER 5R44HL142440-06
  Organization: ALLEVIANT MEDICAL, INC.; City/State: Austin, TX; Project number: 5R44HL142440-06; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-05-13; FY total cost (award amount): 996173; Administering IC: National Heart Lung and Blood Institute; Project title: Transcatheter Device for Congestive Heart Failure Treatment Through Left Atrial Decompression; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

May 13, 2026 Grant Government grant — SBIR: $996,173 (annual award, as published), announced May 13, 2026. Agency: NIH/NHLBI. Source: government award database. source ↗
Mar 10, 2025 Trial start Not phased (device or behavioral study): Alleviant ALLAY-HFrEF Study source ↗
Feb 19, 2025 Grant Government grant — SBIR: $992,964 (annual award, as published), announced Feb 19, 2025. Agency: NIH/NHLBI. Source: government award database. source ↗
Jan 10, 2023 Trial start Not phased (device or behavioral study): Alleviant ALLAY-HF Study source ↗
Jun 30, 2022 Trial start Phase 1: ALLEVIATE-HF-HD Study source ↗
Aug 10, 2021 Trial start Phase 1: ALLEVIATE-HFrEF Study source ↗
Apr 3, 2021 Trial start Not phased (device or behavioral study): Alleviate-HF-2 Study source ↗
Aug 11, 2020 Trial start Phase 1: Alleviate-HF-1 Study source ↗

Estimated primary completion per ClinicalTrials.gov. Dates move.

Last 2 years.

May 13, 2026 Government grant — SBIR: $996,173 (annual award, as published), announced May 13, 2026. Agency: NIH/NHLBI. Source: government award database. source ↗
Feb 19, 2025 Government grant — SBIR: $992,964 (annual award, as published), announced Feb 19, 2025. Agency: NIH/NHLBI. Source: government award database. source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT06812533	Alleviant ALLAY-HFrEF Study	Not phased (device or behavioral study)	Recruiting	Mar 10, 2025	2028-12 (estimated)
NCT05685303	Alleviant ALLAY-HF Study	Not phased (device or behavioral study)	Recruiting	Jan 10, 2023	Dec 1, 2027 (estimated)
NCT04838353	Alleviate-HF-2 Study	Not phased (device or behavioral study)	Completed	Apr 3, 2021	Sep 1, 2023 (actual)
NCT05133089	ALLEVIATE-HFrEF Study	Phase 1	Completed	Aug 10, 2021	Mar 10, 2022 (actual)
NCT05501652	ALLEVIATE-HF-HD Study	Phase 1	Completed	Jun 30, 2022	Aug 22, 2022 (actual)
NCT04583527	Alleviate-HF-1 Study	Phase 1	Completed	Aug 11, 2020	Aug 16, 2021 (actual)

Annual award amounts. Total $3.7M.

Sep 17, 2024 NIH award 1SB1HL174252-01 FY2024: $499,103 awarded for that fiscal year; activity SB1 (SBIR); PI PATE, THOMAS DIFFLEY; recipient as written: ALLEVIANT MEDICAL, INC., Austin, TX. Advancing Commercial Readiness of a No source ↗
Jan 15, 2024 NIH award 2R44HL142440-04 FY2024: $997,944 awarded for that fiscal year; activity R44 (SBIR); PI PATE, THOMAS DIFFLEY; recipient as written: ALLEVIANT MEDICAL, INC., Austin, TX. Transcatheter Device for Congestive He source ↗
Feb 28, 2023 NIH award 5R44HL142440-03 FY2023: $1,017,154 awarded for that fiscal year; activity R44 (SBIR); PI PATE, THOMAS DIFFLEY; recipient as written: ALLEVIANT MEDICAL, INC., Austin, TX. Transcatheter Device for Congestive source ↗
Mar 4, 2022 NIH award 2R44HL142440-02A1 FY2022: $898,558 awarded for that fiscal year; activity R44 (SBIR); PI PATE, THOMAS DIFFLEY; recipient as written: ALLEVIANT MEDICAL, INC., Austin, TX. Transcatheter Device for Congestive source ↗
Aug 31, 2018 NIH award 1R43HL142440-01 FY2018: $313,587 awarded for that fiscal year; activity R43 (SBIR); PI PATE, THOMAS DIFFLEY; recipient as written: ALLEVIANT MEDICAL, INC., Austin, TX. Transcatheter Device for Congestive He source ↗